New combo pill aims to tame stubborn diabetes
NCT ID NCT05814393
First seen Sep 30, 2025 · Last updated May 23, 2026 · Updated 26 times
Summary
This study tested whether adding JW0201 to two standard diabetes medications helps lower blood sugar more effectively in people with type 2 diabetes. About 200 adults whose blood sugar was not well controlled on their current drugs took either JW0201 or a placebo for 24 weeks. The main goal was to see if JW0201 reduced HbA1c, a key measure of long-term blood sugar control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Kangbuk Samsung Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.